Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Debt Ratio: 2020-2025

Historic Debt Ratio for Eton Pharmaceuticals (ETON) over the last 4 years, with Sep 2025 value amounting to 0.29.

  • Eton Pharmaceuticals' Debt Ratio rose 152.46% to 0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66, marking a year-over-year increase of 23.94%. This contributed to the annual value of 0.39 for FY2024, which is 131.04% up from last year.
  • Eton Pharmaceuticals' Debt Ratio amounted to 0.29 in Q3 2025, which was down 2.10% from 0.30 recorded in Q2 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Debt Ratio peaked at 0.39 during Q4 2024, and registered a low of 0.01 during Q1 2021.
  • Over the past 3 years, Eton Pharmaceuticals' median Debt Ratio value was 0.15 (recorded in 2024), while the average stood at 0.17.
  • In the last 5 years, Eton Pharmaceuticals' Debt Ratio surged by 385.30% in 2021 and then tumbled by 36.94% in 2022.
  • Over the past 5 years, Eton Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.05 in 2021, then dropped by 20.06% to 0.04 in 2022, then skyrocketed by 310.71% to 0.17 in 2023, then skyrocketed by 131.04% to 0.39 in 2024, then soared by 152.46% to 0.29 in 2025.
  • Its last three reported values are 0.29 in Q3 2025, 0.30 for Q2 2025, and 0.39 during Q4 2024.